{"url":"https://newsforagent.com/news/2026-11-02/enlighten-clinical-solutions-epro-expansion","markdown_url":"https://newsforagent.com/news/2026-11-02/enlighten-clinical-solutions-epro-expansion.md","title":"Enlighten Clinical Solutions Expands ePRO for Trial Data","headline":"Enlighten Clinical Solutions Adds ePRO to Connect Patient Reports With Trial Data","description":"Enlighten Clinical Solutions expanded its ePRO capabilities, letting trial participants complete assessments remotely.","section":"Product Launches","published_at":"2026-11-02T22:44:32+00:00","modified_at":"2026-11-02T22:44:32+00:00","author":"News Desk","key_takeaways":["Enlighten Clinical Solutions expanded its ePRO offering so participant responses are available inside its integrated EDC environment.","The enhanced ePRO is part of a platform that also includes eTMF, CTMS and additional study management tools.","CEO Jim Harris said study teams need to review and act on patient-reported information without adding another disconnected process."],"companies":[{"name":"Enlighten Clinical Solutions","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00n5s3r/enlighten-clinical-solutions","website":"https://www.enlightenclinical.com"}],"source":{"publisher":"EIN Presswire","title":"Enlighten Clinical Solutions Expands ePRO Capabilities to Connect Patient Reporting with Clinical Trial Data","url":"https://www.einnews.com/pr_news/953995449/enlighten-clinical-solutions-expands-epro-capabilities-to-connect-patient-reporting-with-clinical-trial-data"},"other_sources":[],"tags":["Product Launches","Enlighten Clinical Solutions"],"body_markdown":"[Enlighten Clinical Solutions](https://akta.pro/company-profiles/00n5s3r/enlighten-clinical-solutions) expanded its electronic patient-reported outcomes (ePRO) capabilities to connect patient reporting with its integrated Electronic Data Capture (EDC) environment, the company announced on November 2, 2026. The offering lets participants complete study assessments remotely while their responses become available within the clinical data workflow, according to [EIN Presswire](https://www.einnews.com/pr_news/953995449/enlighten-clinical-solutions-expands-epro-capabilities-to-connect-patient-reporting-with-clinical-trial-data).\n\n## How Enlighten's ePRO Connects to EDC\n\nThe enhanced ePRO allows participants to complete electronic questionnaires remotely, with responses flowing into the company's integrated EDC environment rather than a separate system. Enlighten said the approach reduces the need for separate systems, manual data transfers and additional administrative work. The company said the integrated approach is aimed at sponsors, contract research organizations (CROs) and research sites.\n\nEnlighten described a study scenario in which participants report symptoms between scheduled visits. Electronic assessments can give research teams timely information without requiring participants to return to the site solely to complete a questionnaire, and connecting responses to EDC makes it easier to incorporate patient-reported information into ongoing clinical data review.\n\n\"Patient-reported outcomes give us information we cannot always capture during a scheduled study visit,\" said Jim Harris, Founder and CEO of Enlighten Clinical Solutions. \"But collecting that information is only part of the job. Study teams need to be able to review it, understand it, and act on it without adding another disconnected process. That is what we're focused on with ePRO.\"\n\nThe ePRO capabilities are part of Enlighten's broader clinical technology platform, which brings together EDC, electronic Trial Master File (eTMF), Clinical Trial Management System (CTMS) and additional study management tools. \"Clinical trials involve a great deal of information coming from different people at different times,\" Harris added. \"Our responsibility as a technology provider is to make that information easier to manage.\"\n\n## Enlighten's Platform and Study Base\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Enlighten Clinical Solutions was founded in 2016 and is headquartered in Atlanta. The same records describe a single unified platform integrating EDC, eTMF and CTMS capabilities that connects sponsors, CROs and research sites through one clinical trial environment. The records list ophthalmology as the company's primary specialization, with adaptability for cardiology, oncology and neurology, and note a pancreatic cancer study underway on the platform.\n\nThe company's platform supports global, multi-region clinical research operations, according to the same records, and supports UK-based clinical research initiatives with NHS-affiliated institutions. Enlighten launched its CTMS module at Eyecelerator @ ARVO 2026 in May 2026, completing the EDC, eTMF and CTMS unified platform.\n\nEnlighten directs readers to its [ePRO and integrated clinical trial platform](https://www.enlightenclinical.com) for more information.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}